Search clinical trials for: IV Remodulin

Total 3255 results

MD Stem Cells

Recruiting

Neurologic Stem Cell Treatment Study (NEST)

Stroke | Nervous System Diseases | Diabetic Neuropathies | Neurodegenerative Diseases | Cognitive Impairment | Amyotrophic Lateral Sclerosis | Dementia | Neurological Disorders | Alzheimer Disease | ALS | Traumatic Brain Injury | Cerebral Infarction | Lewy Body Disease | Cerebral Hemorrhage | Frontotemporal Dementia | Progressive... and other conditions

United States, United Arab Emirates
University Hospital, Geneva

Completed

Newborn Phosphocalcic Metabolism After Intravenous Iron Administration During Pregnancy

Iron Induced Hypophosphatemia

Switzerland
Cedars-Sinai Medical Center

Completed

Ultrasound Guided Peripheral IV Insertion (USGPIV)

Anesthesia

United States
HealthPartners Institute

Completed

Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access

Difficult IV Access

United States
MedImmune LLC

Completed

A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease (SPRING)

Chronic Obstructive Pulmonary Disease

United States, Bulgaria, Czech Republic, Poland, United Kingdom, Philippines, Latvia, Lithuania, Ukraine, Hungary
Evasc Medical Systems Corp.

Withdrawn

Canadian eCLIPs™ Safety and Feasibility Study Protocol (CESIS)

Intracranial Aneurysms

Canada
AbbVie

Not yet recruiting

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
Alnylam Pharmaceuticals

Completed

The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

TTR-mediated Amyloidosis

Portugal, Sweden, Brazil, United States, France, Spain, Germany
Methodist Health System

Active, not recruiting

Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit (RESTART)

Gram-Negative Bacterial Infections

United States
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension

Essential Hypertension

United States
Gülçin Özalp Gerçeker

Completed

Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications (nexiva)

Catheter Complications | Catheter Leakage

Turkey
CrystalGenomics, Inc.

Completed

Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults

Healthy

Korea, Republic of
Università degli Studi di Sassari

Completed

Temperament Dimensions and Awakening Salivary Cortisol Levels in ADHD.

Attention Deficit Hyperactivity Disorder

Italy
Radboud University Medical Center

Completed

Reliability of Insulin by Jet Injection

Diabetes Mellitus

Netherlands
Rush University Medical Center

Completed

Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin

Diabetes

United States
AFT Pharmaceuticals, Ltd.

Completed

Maxigesic IV Phase 3 Bunionectomy Study

Post Operative Pain

United States
Polpharma Biologics S.A.

Not yet recruiting

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® (UCESIVE)

Ulcerative Colitis
Sun Pharmaceutical Industries Limited

Completed

Efficacy and Safety Study of SUNPG1623

Active Psoriatic Arthritis

United States
Robert W. Alexander, MD, FICS
Terry, Glenn C., M.D.

Withdrawn

Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy (SVF-BPN)

Nocturia | BPH | BPH With Urinary Obstruction | Prostatism | Prostate Inflammation

United States
Kaiser Permanente

Withdrawn

Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy

Depressive Disorder | Depression | Bipolar Disorder | Major Depressive Disorder | Treatment Resistant Depressive Disorder
Seattle Children's Hospital
Cystic Fibrosis Foundation

Completed

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

Cystic Fibrosis | Chronic Bronchitis

United States
Eli Lilly and Company

Completed

A Study of Ramucirumab (LY3009806) in Healthy Participants

Healthy

United States
Eli Lilly and Company

Completed

A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol

Hyperlipidemia

United States
Meshalkin Research Institute of Pathology of Circulation

Completed

Pilot Study of Autoarterial Remodeling of Bifurcation of the Common Carotid Artery

Stenosis, Internal Carotid Artery

Russian Federation
Neuracle Science Co., LTD.

Completed

A FIH Study to Assess the Safety and Tolerability of NS Intravenous NS101 Infusion

Neurodegenerative Diseases

Canada
Lahey Clinic

Terminated

Efficacy of Near-Infrared Vein Imaging for Difficult IV Placement

Catheterization, Peripheral

United States
Northwell Health

No longer available

Compassionate Use of Omegaven IV Fat Emulsion

Liver Disease | Cholestasis

United States
Pfizer

Completed

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859

Healthy

United States
Milton S. Hershey Medical Center

Terminated

Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH (aSAH)

Stroke | Subarachnoid Hemorrhage

United States
Culpeper Surgery Center
Cumberland Pharmaceuticals

Unknown

A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac

Chronic Pelvic Pain

United States
Hector Hernandez

Approved for marketing

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

Total Parenteral Nutrition-induced Cholestasis

United States
GlaxoSmithKline

Completed

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

Carcinoma, Renal Cell

United States
Bausch Health Americas, Inc.

Completed

A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab

Psoriasis

United States
Genentech, Inc.

Completed

An Absolute Bioavailability Study in Healthy Participants Comparing Oral to Intravenous Administration of GDC-0973 (Cobimetinib)

Healthy Volunteers
Eli Lilly and Company

Completed

Safety Study of LY3041658 in Healthy Participants

Healthy

United States
Eli Lilly and Company

Completed

Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis

Inflammatory Arthritis

Bulgaria, Georgia, Moldova, Republic of, Romania
Clavis Pharma

Completed

A Study of CP-4126 in Patients With Advanced Pancreatic Cancer

Advanced Adenocarcinoma of Pancreas

Norway, Belgium
The Cleveland Clinic

Terminated

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

Type 1 Diabetes | Type 2 Diabetes | Diabetic Ketoacidosis

United States
University of Edinburgh
NHS Lothian

Completed

Cardiovascular Effects of Apelin In Healthy Volunteers

Healthy

United Kingdom
Vejle Hospital

Completed

Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer (NeoToc)

Breast Cancer

Denmark
BeiGene

Recruiting

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

China, Georgia, Moldova, Republic of
Celularity Incorporated

Terminated

Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM (CYNK001GBM01)

Glioblastoma Multiforme | Molecular Mechanisms of Pharmacological Action | Giant Cell Glioblastoma | Astrocytoma, Grade IV | Physiological Effects of Drugs | Peripheral Nervous System Agents | Analgesics | Analgesics, Non-narcotic | Cyclophosphamide | Immunosuppressive Agents | Immunologic Factors | Antiviral... and other conditions

United States
Bayside Health
Australian and New Zealand College of Anaesthetists

Completed

Limiting IV Chloride to Reduce AKI After Cardiac Surgery (LICRA)

Patients Undergoing Cardiothoracic Surgery

Australia
Italian Society of Nephrology
European Commission; Memorial University of Newfoundland

Terminated

Bicarbonate v Saline to Prevent Contrast Nephropathy

Kidney Failure, Acute | Contrast Media

Italy
Hospital for Special Surgery, New York

Completed

Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy (SCB & IV Dex)

Pain | Shoulder Arthroscopy

United States
Odense University Hospital
Novo Nordisk A/S; Department of Nephrology, Odense University Hospital; The A... and other collaborators

Recruiting

Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH)

Kidney Failure, Chronic | Kidney Injury | Risk Reduction | Contrast-induced Nephropathy

Denmark
Sanofi

Terminated

Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors

Breast Cancer | Gastric Cancer | Neoplasm | Lung Neoplasm Malignant | Neoplasm Malignant

Belgium, Korea, Republic of, United States, Taiwan, Spain, France
Assiut University

Completed

Preoperative Immunonutrition and Cardiac Patients

Cardiac Function

Egypt
AGC Biologics S.p.A.

Completed

A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors

Advanced Solid Tumors

Italy
University of Chicago

Completed

Ultrasound-Guided Peripheral Venous Access Using AccuCath (AccuCath)

Intravenous Access

Search clinical trials for: IV Remodulin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations